Safety of intravenous iron in clinical practice: Implications for anemia management protocols

被引:54
作者
Aronoff, GR [1 ]
机构
[1] Univ Louisville, Dept Med, Kidney Dis Program, Div Nephrol, Louisville, KY 40292 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2004年 / 15卷 / 12期
关键词
D O I
10.1097/01.ASN.0000143815.15433.87
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:S99 / S106
页数:8
相关论文
共 84 条
[1]  
Ahluwalia N, 2004, AM J CLIN NUTR, V79, P516
[2]  
Allen JR, 2000, PERITON DIALYSIS INT, V20, P674
[3]   Impact of dialysis dose and membrane on infection-related hospitalization and death: Results of the HEMO study [J].
Allon, M ;
Depner, TA ;
Radeva, M ;
Bailey, J ;
Beddhu, S ;
Butterly, D ;
Coyne, DW ;
Gassman, JJ ;
Kaufman, AM ;
Kaysen, GA ;
Lewis, JA ;
Schwab, SJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (07) :1863-1870
[4]  
*AM REG INC, 2003, IN2340 AM REG INC
[5]   DEFEROXAMINE INCREASES THE SUSCEPTIBILITY OF BETA-THALASSEMIC, IRON-OVERLOADED MICE TO INFECTION WITH LISTERIA-MONOCYTOGENES [J].
AMPEL, NM ;
BEJARANO, GC ;
SAAVEDRA, M .
LIFE SCIENCES, 1992, 50 (18) :1327-1332
[6]   Iron sucrose in hemodialysis patients: Safety of replacement and maintenance regimens [J].
Aronoff, GR ;
Bennett, WM ;
Blumenthal, S ;
Charytan, C ;
Pennell, JP ;
Reed, J ;
Rothstein, M ;
Strom, J ;
Wolfe, A ;
Van Wyck, D ;
Yee, J .
KIDNEY INTERNATIONAL, 2004, 66 (03) :1193-1198
[7]  
AUERBACH M, 1988, J LAB CLIN MED, V111, P566
[8]   Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation [J].
Barton, JC ;
Barton, EH ;
Bertoli, LF ;
Gothard, CH ;
Sherrer, JS .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (01) :27-32
[9]   Incidence of side-effects associated with high-dose ferric gluconate in patients with severe chronic renal failure [J].
Bastani, B ;
Jain, A ;
Pandurangan, G .
NEPHROLOGY, 2003, 8 (01) :8-10
[10]   The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease [J].
Blaustein, DA ;
Schwenk, MH ;
Chattopadhyay, J ;
Singh, H ;
Daoui, R ;
Gadh, R ;
Avram, MM .
KIDNEY INTERNATIONAL, 2003, 64 :S72-S77